Article

The role of age in choosing high-efficacy treatment for multiple sclerosis – an Austrian MS Database study

2025-07-15

Abstract excerpt

<h4>Background</h4> Treatment strategy for relapsing multiple sclerosis (RMS) is increasingly shifting towards first-line use of high-efficacy DMT (H-DMT). However, DMT efficacy declines with increasing age and the benefit of first line H-DMT at higher age remains unclear. Here, we aimed to investigate whether the superiority of H-DMT over moderate-efficacy DMT (M-DMT) depends on age. <h4>Methods</h4> Using the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d3e05560-ae78-5264-bc11-50bdbb01c15a
DOI: 10.1101/2025.07.14.25331511

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The role of age in choosing high-efficacy treatment for multiple sclerosis – an Austrian MS Database studyDOI 10.1101/2025.07.14.25331511Read

Effect of Early Treatment Intensity on Progression Independent of Relapse Activity and Disability Accumulation in Multiple SclerosisSemantic proximity Read

Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.Semantic proximity Read

Characterisation of MS phenotypes across the age span using a novel data set integrating 34 clinical trials (NO.MS cohort): Age is a key contributor to presentation.Semantic proximity Read

Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factorsSemantic proximity Read

Associations of DMT therapies with COVID-19 severity in multiple sclerosisSemantic proximity Read

Associations of DMT Therapies with COVID-19 Severity in Multiple Sclerosis: An International Cohort StudySemantic proximity Read

The Austrian MS Database and the Austrian MS Cohort – a national effort towards data harmonization and prospective data collectionSemantic proximity Read

Comparative effectiveness of natalizumab and fingolimod and injectable therapies in patients with pediatric multiple sclerosis: A registry-based retrospective cohort studySemantic proximity Read

The relationship of age with the clinical phenotype in multiple sclerosis.Semantic proximity Read

Sex- and age-related shift of relapse phenotypes in a cohort of relapsing multiple sclerosis patients: Post hoc analysis from the OPERA phase 3 trials.Semantic proximity Read

Quantifying MS Progression in the Era of Highly Effective Therapy: Trial Design ImplicationsSemantic proximity Read

The association between disability progression, relapses, and treatment in early relapse onset MS: an observational, multi-center, longitudinal cohort studySemantic proximity Read